SE501592C2 - Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantförening - Google Patents
Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantföreningInfo
- Publication number
- SE501592C2 SE501592C2 SE8603284A SE8603284A SE501592C2 SE 501592 C2 SE501592 C2 SE 501592C2 SE 8603284 A SE8603284 A SE 8603284A SE 8603284 A SE8603284 A SE 8603284A SE 501592 C2 SE501592 C2 SE 501592C2
- Authority
- SE
- Sweden
- Prior art keywords
- acid
- xanthate
- sodium
- potassium
- antiviral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3527871 | 1985-08-02 | ||
| DE3620939 | 1986-06-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8603284D0 SE8603284D0 (sv) | 1986-08-01 |
| SE8603284L SE8603284L (sv) | 1987-02-03 |
| SE501592C2 true SE501592C2 (sv) | 1995-03-20 |
Family
ID=25834701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8603284A SE501592C2 (sv) | 1985-08-02 | 1986-08-01 | Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantförening |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4851435A (de) |
| JP (1) | JPH0618786B2 (de) |
| AU (1) | AU585380B2 (de) |
| BE (1) | BE905195A (de) |
| CA (1) | CA1295944C (de) |
| CH (1) | CH673224A5 (de) |
| DK (1) | DK369186A (de) |
| FR (1) | FR2591483B1 (de) |
| GB (1) | GB2178957B (de) |
| GR (1) | GR862030B (de) |
| IT (1) | IT1213453B (de) |
| LU (1) | LU86533A1 (de) |
| NL (1) | NL8601895A (de) |
| SE (1) | SE501592C2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT392906B (de) * | 1987-10-08 | 1991-07-10 | Hoffmann La Roche | Pharmazeutische praeparate zur oralen verabreichung |
| CA2010511A1 (en) * | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
| AU4159596A (en) * | 1994-11-14 | 1996-06-06 | Ct-Holding Sa | Antiviral and antitumor pharmaceutical compositions |
| DE10117728A1 (de) * | 2001-04-09 | 2002-10-17 | Biosphings Ag | Pharmazeutische Formulierungen für Xanthogenate |
| DE10156617A1 (de) * | 2001-11-17 | 2003-05-28 | Biosphings Ag | Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus |
| DE10343365A1 (de) * | 2003-09-17 | 2005-04-14 | Biosphings Ag | Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| ATE521355T1 (de) * | 2004-05-19 | 2011-09-15 | Los Angeles Biomed Res Inst | Verwendung eines detergens zur nicht- chirurgischen entfernung von fett |
| DE102006014390A1 (de) | 2006-03-29 | 2007-10-04 | Biosphings Ag | Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung |
| CA2691807A1 (en) * | 2007-07-03 | 2009-01-08 | Lumavita Ag | Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| CA2827643C (en) | 2011-02-18 | 2019-05-07 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
| US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4020183A (en) * | 1974-12-03 | 1977-04-26 | Ortho Pharmaceutical Corporation | Nonionic surface active anti-herpes simplex viral agents |
| CA1174978A (en) * | 1980-11-26 | 1984-09-25 | Arthur Scherm | Xanthates |
| KR870001238B1 (ko) * | 1980-11-26 | 1987-06-26 | 메르츠+캄패니 게엠베하 앤드 캄패니 | 크산틴산염의 제조방법 |
| DK315482A (da) * | 1981-07-20 | 1983-01-21 | Kimberly Clark Co | Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden |
-
1986
- 1986-07-21 IT IT8621192A patent/IT1213453B/it active
- 1986-07-22 NL NL8601895A patent/NL8601895A/nl not_active Application Discontinuation
- 1986-07-23 CH CH2960/86A patent/CH673224A5/de not_active IP Right Cessation
- 1986-07-29 BE BE0/216195A patent/BE905195A/fr not_active IP Right Cessation
- 1986-07-29 AU AU60648/86A patent/AU585380B2/en not_active Ceased
- 1986-07-30 CA CA000515025A patent/CA1295944C/en not_active Expired - Fee Related
- 1986-07-30 LU LU86533A patent/LU86533A1/fr unknown
- 1986-07-31 GR GR862030A patent/GR862030B/el unknown
- 1986-08-01 DK DK369186A patent/DK369186A/da not_active Application Discontinuation
- 1986-08-01 US US06/892,346 patent/US4851435A/en not_active Expired - Lifetime
- 1986-08-01 JP JP61180216A patent/JPH0618786B2/ja not_active Expired - Lifetime
- 1986-08-01 FR FR868611220A patent/FR2591483B1/fr not_active Expired - Fee Related
- 1986-08-01 GB GB8618820A patent/GB2178957B/en not_active Expired
- 1986-08-01 SE SE8603284A patent/SE501592C2/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6064886A (en) | 1987-02-05 |
| GR862030B (en) | 1986-12-24 |
| GB8618820D0 (en) | 1986-09-10 |
| BE905195A (fr) | 1987-01-29 |
| DK369186D0 (da) | 1986-08-01 |
| SE8603284D0 (sv) | 1986-08-01 |
| GB2178957B (en) | 1989-12-28 |
| US4851435A (en) | 1989-07-25 |
| IT1213453B (it) | 1989-12-20 |
| FR2591483B1 (fr) | 1990-08-10 |
| CA1295944C (en) | 1992-02-18 |
| CH673224A5 (de) | 1990-02-28 |
| NL8601895A (nl) | 1987-03-02 |
| DK369186A (da) | 1987-02-03 |
| IT8621192A0 (it) | 1986-07-21 |
| LU86533A1 (fr) | 1988-02-02 |
| JPH0618786B2 (ja) | 1994-03-16 |
| GB2178957A (en) | 1987-02-25 |
| AU585380B2 (en) | 1989-06-15 |
| JPS6259223A (ja) | 1987-03-14 |
| FR2591483A1 (fr) | 1987-06-19 |
| SE8603284L (sv) | 1987-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE501592C2 (sv) | Antivirus- och antitumörkomposition innefattande ett antivirus- och antitumörxantat och en jonisk adjuvantförening | |
| Huleihel et al. | Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses | |
| EP0823428A3 (de) | Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung | |
| WO1998040102A1 (en) | Cytoprotective agents comprising monoamine oxidase inhibitors | |
| US5491135A (en) | Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals | |
| JP3250804B2 (ja) | 治療用ペプチド | |
| AU617115B2 (en) | A pharmaceutical combination product and the preparation and use thereof | |
| McGRATH et al. | Effects of GLQ223™ on HIV Replication in Human Monocyte/Macrophages Chronically Infected In Vitro with HIV | |
| Soike et al. | Acyclovir treatment of experimental simian varicella infection of monkeys | |
| KR960000432B1 (ko) | 제약학적 생성물 | |
| DE69501081T2 (de) | Oligonukleotide mit anti-cytomegalovirus wirkung | |
| EP0610444B1 (de) | Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen | |
| Dziarski | Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin. | |
| Collins et al. | Comparison of activity of herpes virus inhibitors | |
| Sheldon et al. | Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes—clues to its clinical action? | |
| Pouillart et al. | Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon | |
| Hoover et al. | Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy | |
| US3859433A (en) | Antiviral treatment | |
| KR100718030B1 (ko) | 변형성 관절증 치료제 | |
| US9351960B2 (en) | Agent for the treatment of viral hepatitis C | |
| RU2001917C1 (ru) | Способ лечени патологических состо ний, сопровождающихс нехваткой GT РНК | |
| CS275793B6 (en) | Production method of the antivirus and antitumour agent | |
| US4822783A (en) | Method for treating HTLV-I using streptovaricin C compounds | |
| Bucknall | Why aren't antivirals effective when administered intranasally? | |
| GB2224649A (en) | Fusidic acid anti-viral compositions |